[go: up one dir, main page]

AR077526A1 - Metodo para la sintesis de (1s,2r)- milnacipran - Google Patents

Metodo para la sintesis de (1s,2r)- milnacipran

Info

Publication number
AR077526A1
AR077526A1 ARP100100245A ARP100100245A AR077526A1 AR 077526 A1 AR077526 A1 AR 077526A1 AR P100100245 A ARP100100245 A AR P100100245A AR P100100245 A ARP100100245 A AR P100100245A AR 077526 A1 AR077526 A1 AR 077526A1
Authority
AR
Argentina
Prior art keywords
formula
reaction
amide
milnacipran
phthalimide
Prior art date
Application number
ARP100100245A
Other languages
English (en)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR077526A1 publication Critical patent/AR077526A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicacion 1: Un método para sintetizar una sal de adicion de ácido farmacéuticamente aceptable de (1S,2R)-milnaciprán de la formula (1), que comprende los siguientes pasos sucesivos: (a) reaccion de fenilacetonitrilo y de (R)-epiclorhidrina en presencia de una base que contiene un metal alcalino, seguida por un tratamiento básico, y luego por un tratamiento ácido para obtener la lactona de la formula (2); (b) reaccion de la lactona (2) obtenida en el paso (a) previo con MNEt2, en donde M representa un metal alcalino, o con NHEt2 en presencia de un complejo de ácido de Lewis-amina en donde la amina es seleccionada entre dietilamina, trietilamina, diisopropiletilamina, N,N-dietilanilina, N,N-dimetilbencilamina, N-metilpiperidina, N-metilmorfolina, N,N'-dimetilpiperazina y hexametilentetramina, para obtener el amida-alcohol de la formula (3; (c) reaccion del amida-alcohol de formula (3) obtenido en el paso (b) previo con cloruro de tionilo para obtener la amida clorada de la formula (4; (d) reaccion de la amida dorada de formula (4) obtenida en el paso (c) previo con una sal de ftalimida, tal como la sal de potasio, para obtener el derivado de ftalimida de la formula (5); (e) hidrolisis del grupo ftalimida del derivado de ftalimida de formula (5) obtenido en el paso (d) previo, para obtener (1S,2R)-milnaciprán, y (f) salificacion del (1S,2R)-milnaciprán obtenido en el paso (e) previo en un sistema adecuado de solventes, en presencia de un ácido farmacéuticamente aceptable.
ARP100100245A 2009-01-29 2010-01-29 Metodo para la sintesis de (1s,2r)- milnacipran AR077526A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0950552A FR2941454B1 (fr) 2009-01-29 2009-01-29 Proced de synthese du (1s,2r)-milnacipran

Publications (1)

Publication Number Publication Date
AR077526A1 true AR077526A1 (es) 2011-09-07

Family

ID=40920574

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP100100245A AR077526A1 (es) 2009-01-29 2010-01-29 Metodo para la sintesis de (1s,2r)- milnacipran
ARP190101513A AR115475A2 (es) 2009-01-29 2019-06-04 Método para la síntesis de (1s,2r)-milnaciprán

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP190101513A AR115475A2 (es) 2009-01-29 2019-06-04 Método para la síntesis de (1s,2r)-milnaciprán

Country Status (23)

Country Link
US (1) US8604241B2 (es)
EP (1) EP2391599B1 (es)
JP (1) JP5646509B2 (es)
KR (1) KR101719011B1 (es)
CN (2) CN110204455A (es)
AR (2) AR077526A1 (es)
AU (1) AU2010209686B2 (es)
BR (1) BRPI1007404B8 (es)
CA (1) CA2750488C (es)
ES (1) ES2472695T3 (es)
FR (1) FR2941454B1 (es)
GE (1) GEP20135903B (es)
IL (1) IL214241A (es)
MA (1) MA33025B1 (es)
MX (1) MX2011007846A (es)
NZ (1) NZ594291A (es)
PL (1) PL2391599T3 (es)
RU (1) RU2521342C2 (es)
TN (1) TN2011000363A1 (es)
TW (1) TWI455911B (es)
UA (1) UA104884C2 (es)
WO (1) WO2010086394A1 (es)
ZA (1) ZA201105414B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944011B1 (fr) * 2009-04-03 2011-05-20 Pf Medicament Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments.
WO2011158249A1 (en) * 2010-06-16 2011-12-22 Glenmark Generics Limited Process for preparation of milnacipran intermediate and its use in preparation of pure milnacipran
WO2012046247A2 (en) * 2010-10-06 2012-04-12 Msn Laboratories Limited Process for the preparation of (±m1r(s), 2srr)l-2-(aminomethyl)-n,n-diethyl-l-phenylcyclopropane carboxamide hydrochloride
ES2613709T3 (es) * 2011-01-24 2017-05-25 Bayer Intellectual Property Gmbh Procedimiento para la preparación de 2,2-difluoroetilamina a partir de 2,2-difluoro-1-cloroetano
US9416109B2 (en) * 2012-02-17 2016-08-16 Eisai R&D Management Co., Ltd. Methods and compounds useful in the synthesis of orexin-2 receptor antagonists
WO2014009767A1 (en) 2012-07-07 2014-01-16 Micro Labs Limited An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts
EP2805936A1 (en) 2013-05-20 2014-11-26 Cosma S.p.A. Process for preparing levomilnacipran HCL
WO2014203277A2 (en) * 2013-06-19 2014-12-24 Msn Laboratories Private Limited Process for the preparation of (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanearboxamide hydrochloride
CN103694162B (zh) * 2014-01-03 2015-09-02 上海现代制药股份有限公司 (1s,2r)-1-苯基2-(酞酰亚胺)甲基-n,n-二乙基-环丙甲酰胺的制备方法
CN104058992A (zh) * 2014-06-13 2014-09-24 上海现代制药股份有限公司 左旋米那普仑盐酸盐的晶型
BR112017006115A2 (pt) 2014-10-03 2017-12-19 Purac Biochem Bv método para a preparação de n,n-dialquilactamida
EP3230258B1 (en) 2014-11-04 2019-06-26 Química Sintética, S.A. Process for the preparation of (1s,2r)-milnacipran
CN106083638A (zh) * 2016-07-07 2016-11-09 佛山市隆信医药科技有限公司 一种盐酸左旋米那普仑的制备方法
CN111175387B (zh) * 2018-11-13 2022-06-07 成都康弘药业集团股份有限公司 一种米那普仑异构体的检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508035A1 (fr) 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2581059B1 (fr) 1985-04-25 1988-04-22 Pf Medicament Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z)
FR2640972B1 (es) * 1988-12-28 1991-04-19 Pf Medicament
WO1995022521A1 (en) 1994-02-22 1995-08-24 Asahi Kasei Kogyo Kabushiki Kaisha Aminoalkylcyclopropane derivative
JPH0834765A (ja) * 1994-02-22 1996-02-06 Asahi Chem Ind Co Ltd アミノアルキルシクロプロパン誘導体
US7309799B2 (en) 2004-06-01 2007-12-18 Collegium Pharmaceutical, Inc. Methods for the synthesis of milnacipran and congeners thereof
JP4712320B2 (ja) 2004-06-16 2011-06-29 住友化学株式会社 2−オキソ−1−フェニル−3−オキサビシクロ[3.1.0]ヘキサンの製造方法
JP4418717B2 (ja) * 2004-06-24 2010-02-24 住友化学株式会社 (z)−1−フェニル−1−ジエチルアミノカルボニル−2−アミノメチルシクロプロパン塩酸塩の製造方法
CN100579954C (zh) 2004-06-25 2010-01-13 住友化学株式会社 (z)-1-苯基-1-二乙氨基羰基-2-羟甲基环丙烷的制造方法
JP4828863B2 (ja) 2005-01-28 2011-11-30 住友化学株式会社 (z)−1−フェニル−1−(n,n−ジエチルアミノカルボニル)−2−フタルイミドメチルシクロプロパンの製造方法
KR100772244B1 (ko) * 2005-07-20 2007-11-01 안국약품 주식회사 밀나시프란염산염의 제조방법
CN102986288B (zh) 2009-12-04 2016-12-07 交互数字专利控股公司 用于混合网络中的汇聚网关的扩展本地ip接入

Also Published As

Publication number Publication date
CA2750488A1 (en) 2010-08-05
AR115475A2 (es) 2021-01-20
CN102300840A (zh) 2011-12-28
RU2011135326A (ru) 2013-03-10
TN2011000363A1 (en) 2013-03-27
RU2521342C2 (ru) 2014-06-27
NZ594291A (en) 2012-11-30
WO2010086394A1 (en) 2010-08-05
BRPI1007404B8 (pt) 2021-05-25
EP2391599B1 (en) 2014-04-09
MA33025B1 (fr) 2012-02-01
TWI455911B (zh) 2014-10-11
IL214241A0 (en) 2011-09-27
AU2010209686A1 (en) 2011-08-18
IL214241A (en) 2015-03-31
BRPI1007404A2 (pt) 2016-02-16
US20110295036A1 (en) 2011-12-01
GEP20135903B (en) 2013-08-12
FR2941454B1 (fr) 2011-04-01
ES2472695T3 (es) 2014-07-02
UA104884C2 (uk) 2014-03-25
JP2012516307A (ja) 2012-07-19
CN110204455A (zh) 2019-09-06
EP2391599A1 (en) 2011-12-07
AU2010209686B2 (en) 2014-06-05
MX2011007846A (es) 2011-12-14
FR2941454A1 (fr) 2010-07-30
KR101719011B1 (ko) 2017-03-22
PL2391599T3 (pl) 2014-09-30
US8604241B2 (en) 2013-12-10
KR20110108409A (ko) 2011-10-05
ZA201105414B (en) 2012-03-28
TW201031623A (en) 2010-09-01
BRPI1007404B1 (pt) 2020-10-13
JP5646509B2 (ja) 2014-12-24
CA2750488C (en) 2016-12-13

Similar Documents

Publication Publication Date Title
AR077526A1 (es) Metodo para la sintesis de (1s,2r)- milnacipran
JP5186722B2 (ja) スルフリルフルオリドを用いるフッ素化反応
AR074845A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
EA201591093A1 (ru) Способы синтеза аналога простациклина
EA201270550A1 (ru) Процесс получения соединений для применения в качестве ингибиторов sglt2
US20090250658A1 (en) Dehydroxyfluorination Agent
AR079015A1 (es) Acidos 3-fenilpropionicos sustituidos, metodo de preparacion y uso de los mismos
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
PE20090698A1 (es) Derivados de alcoholes de 1-fenil-2-piridinilalquilo como inhibidores de la fosfodiesterasa
RU2015142826A (ru) Способ получения натриевой соли (2s, 5r)-2-карбоксамидо-7-оксо-6-сульфоокси-1, 6-диаза-бицикло[3.2.1]октана
EA201290872A1 (ru) Способ получения бензоксаборолов
CO6290754A2 (es) Método para producir bicarbonato de arginina
RU2018132264A (ru) Промежуточные продукты в синтезе эрибулина и соответствующие способы синтеза
AR063449A1 (es) Proceso quimico para derivados de quinazolina, intermediarios
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
PE20061422A1 (es) Tigeciclina y metodos para preparar 9-nitrominociclina
AR107494A1 (es) Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y “azd9291 anilina” o una sal de la misma
AR061890A1 (es) Sal xinafoato del etil ester de la 1-[[5-(1s)-aminoetil)-2-[8-metoxi-2(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-(4r)-[(ciclopropil-carbonil)amino]-l-prolina.
MX2021006065A (es) Procesos para la preparacion de propanedioles nitrosilados, composiciones que los comprenden y usos medicos de estos.
Mao et al. A practical, chemoselective approach to O-methylation of carboxylic acids with dimethyl malonate
CN103709194B (zh) 光学活性的羟基保护的脂肪族磷酸酯的制备方法
AR047686A1 (es) Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable
Fisher et al. Asymmetric syntheses of potential anti-malarial drugs designed from Fieser's 2-hydroxy-3-(2-methyloctyl) naphthalene-1, 4-dione.
RU2010114505A (ru) Способ получения 2,2'-дихлордиэтилформаля
MA35806B1 (fr) Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenil) propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Legal Events

Date Code Title Description
FC Refusal